Anti-Cleaved Caspase-7 antibody [EPR22840-25]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal Caspase-7 antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 13 publications.
View Alternative Names
MCH3, CASP7, Caspase-7, CASP-7, Apoptotic protease Mch-3, CMH-1, ICE-like apoptotic protease 3, ICE-LAP3
- IP
Unknown
Immunoprecipitation - Anti-Cleaved Caspase-7 antibody [EPR22840-25] (AB256469)
Cleaved Caspase-7 was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) treated with 1μM Staurosporine for 3h whole cell lysate 10μg with ab256469 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab256469. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/1000 dilution.
Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) treated with 1μM Staurosporine for 3h whole cell lysate 10μg
Lane 2 : ab256469 IP in HeLa treated with 1μM Staurosporine for 3h whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab256469 in HeLa treated with 1μM Staurosporine for 3h whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 15 seconds.
This antibody reacts with an unidentifiable protein around 48 kDa.
All lanes:
Immunoprecipitation - Anti-Cleaved Caspase-7 antibody [EPR22840-25] (ab256469)
Predicted band size: 34 kDa
Observed band size: 18 kDa
false
- WB
Lab
Western blot - Anti-Cleaved Caspase-7 antibody [EPR22840-25] (AB256469)
Caspase-7 is activated upon apoptotic induction. Caspase-7 p22 subunit (22 kDa) and p20 subunit (18 kDa) are observed. The molecular weight observed is consistent with what has been described in the literature (PMID : 16352606). This antibody reacts with an unidentifiable protein around 48 kDa. ab256469 was shown to specifically react with Caspase-7 in wild-type HAP1 cells as signal was lost in Caspase-7 knockout cells. Wild-type and Caspase-7 knockout samples were subjected to SDS-PAGE. ab256469 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ instrument using the ECL technique. Blocking and Diluting Buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cleaved Caspase-7 antibody [EPR22840-25] (ab256469) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 1 µM staurosporine for 3 hours whole cell lysate at 20 µg
Lane 3:
Untreated wild-type HAP1 whole cell lysate at 20 µg
Lane 4:
Wild-type HAP1 treated with 1 µM staurosporine for 3 hours whole cell lysate at 20 µg
Lane 5:
Untreated caspase-7 knockout HAP1 whole cell lysate at 20 µg
Lane 6:
Caspase-7 knockout HAP1 treated with 1 µM staurosporine for 3 hours whole cell lysate at 20 µg
Lane 7:
Mouse spleen lysate at 20 µg
Lane 8:
Rat spleen lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 34 kDa
Observed band size: 18 kDa,22 kDa
false
Exposure time: 26s
Related conjugates and formulations (4)
-
702 Alexa Fluor® 680
Goat Anti-Rabbit IgG H&L (Alexa Fluor® 680) preadsorbed
-
702 Alexa Fluor® 680
Donkey Anti-Rabbit IgG H&L (Alexa Fluor® 680)
-
775 Alexa Fluor® 750
Goat Anti-Rabbit IgG H&L (Alexa Fluor® 750) preadsorbed
-
Donkey Anti-Rabbit IgG H&L (HRP)
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cleaved Caspase-7 plays a role by executing apoptosis through cleaving cellular substrates after aspartic acid residues. It operates independently or as part of the apoptosome complex which includes other caspases and protein factors. This complex contributes to the orderly dismantling of cellular structures during programmed cell death ensuring the removal of damaged or unnecessary cells in a controlled manner.
Pathways
Cleaved Caspase-7 participates actively in the apoptosis signaling pathway and to a lesser extent in the inflammatory response. It acts downstream in the cascade initiated by pro-apoptotic signals wherein it shares significant functional similarities with Caspase-3. Together with Caspase-8 which acts earlier in the pathway these proteins form a network that ensures the fidelity of programmed cell death. Caspase-8 initiates the cascade leading to the activation of Caspase-7.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
PLoS neglected tropical diseases 19:e0013443 PubMed40892762
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 14:e70907 PubMed40263929
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 21:1738-1755 PubMed39006851
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1378305 PubMed38779664
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 20:e1011981 PubMed38354122
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of chronic obstructive pulmonary disease 18:669-682 PubMed37114104
2023
Applications
Unspecified application
Species
Unspecified reactive species
Computational and mathematical methods in medicine 2022:6260202 PubMed36193200
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:522 PubMed35661704
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 20:101356 PubMed35339891
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 69:311-320 PubMed34962825
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com